PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, ...
Shakespeare’s Sonnet 18 and an Irish song tradition inspired Paul McCartney on The Beatles‘ “I Saw Her Standing There.” Paul used many of his literary and musical favorites in his songs. In The Lyrics ...
Sonnet BioTherapeutics Holdings, Inc. announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent related to its modified form of Interleukin-18, ...
Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18 Binding Protein Resistant or IL-18 BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with ...
In the spring of 2016, Toronto guitarist Trevor Giancola assembled his dream band: a quartet featuring Seamus Blake, Rick Rosato, and Adam Arruda, three ex-pat Canadians making waves on the ...
Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory IL-18 ...